{"id":1851,"date":"2026-01-12T13:07:31","date_gmt":"2026-01-12T13:07:31","guid":{"rendered":"https:\/\/admarebio.com\/news-events\/news-insights\/"},"modified":"2026-06-26T13:07:31","modified_gmt":"2026-06-26T13:07:31","slug":"domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg","status":"publish","type":"post","link":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/","title":{"rendered":"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG"},"content":{"rendered":"\n

Montr\u00e9al, Canada, Strasbourg, France, Boston, \u00c9tats-Unis:<\/strong> Kainova Th\u00e9rapeutiques (\u00ab Kainova \u00bb ou \u00ab la Soci\u00e9t\u00e9 \u00bb), un catalyseur de traitements r\u00e9volutionnaires pour les patients en immuno-oncologie et en inflammation, a annonc\u00e9 aujourd’hui son changement de marque. Le nouveau nom et la nouvelle marque refl\u00e8tent la dynamique clinique de la soci\u00e9t\u00e9, son ambition mondiale et sa pr\u00e9paration pour la prochaine \u00e9tape de croissance strat\u00e9gique, port\u00e9e par un pipeline mature de th\u00e9rapies modulant les r\u00e9cepteurs coupl\u00e9s aux prot\u00e9ines G (RCPG).<\/p>\n\n\n\n

Le nom \u00ab Kainova \u00bb combine \u00ab Kairos \u00bb, le moment opportun ou d\u00e9cisif, et \u00ab Nova \u00bb, symbolisant l’innovation et le renouveau. Il refl\u00e8te la transformation et l\u2019ambition de la Soci\u00e9t\u00e9, son dynamisme d\u2019innovation, sa d\u00e9termination \u00e0 d\u00e9livrer des r\u00e9sultats et son engagement envers des th\u00e9rapies qui transforment v\u00e9ritablement la vie des patients. Construite sur une base scientifique solide, une plateforme de d\u00e9couverte propri\u00e9taire, une approche de d\u00e9veloppement int\u00e9gr\u00e9e et un leadership exp\u00e9riment\u00e9, la nouvelle marque souligne l’engagement de Kainova envers l’excellence clinique, la cr\u00e9ation de valeur et un impact durable.<\/p>\n\n\n\n

\u00ab Le changement de marque ne constitue pas une rupture avec nos racines scientifiques ou strat\u00e9giques \u00bb, <\/em>a d\u00e9clar\u00e9 Sean A. MacDonald, Chef de la Direction de Kainova Th\u00e9rapeutiques. \u00ab C’est l’expression plus claire de qui nous sommes aujourd’hui et de l’impact que nous voulons d’apporter aux patients. Cela met en \u00e9vidence la continuit\u00e9 entre nos succ\u00e8s pass\u00e9s et la voie de croissance que nous envisageons pour l’avenir. Plus que tout, Kainova Th\u00e9rapeutiques incarne notre conviction que le meilleur est toujours possible \u00bb.<\/em><\/p>\n\n\n\n

S’appuyant sur des d\u00e9cennies d’expertise scientifique et m\u00e9dicale et sur un historique \u00e9prouv\u00e9 de collaborations avec le secteur pharmaceutique, Kainova fait progresser des th\u00e9rapies innovantes et cliniquement diff\u00e9renci\u00e9es con\u00e7ues pour lib\u00e9rer le potentiel inexploit\u00e9 des RCPGs. Kainova s\u2019appuie sur une approche avant-gardiste et enti\u00e8rement int\u00e9gr\u00e9e en mati\u00e8re de d\u00e9couverte de m\u00e9dicaments ciblant les RCPG et de d\u00e9veloppement optimal, faisant progresser efficacement les programmes du concept \u00e0 la clinique et renfor\u00e7ant sa position de leader dans le domaine. Les principaux programmes de la Soci\u00e9t\u00e9 comprennent le DT-7012, un anticorps anti-CCR8 d\u00e9pl\u00e9tant les Treg, dot\u00e9 de propri\u00e9t\u00e9s comp\u00e9titives et actuellement en phase I\/II pour les tumeurs solides, le DT-9046, un antagoniste PAR2 biais\u00e9, premier de sa cat\u00e9gorie et en pr\u00e9clinique r\u00e9glementaire pour les maladies inflammatoires, et le DT-9081, un antagoniste du r\u00e9cepteur EP4 pr\u00eat pour la phase II pour les tumeurs solides.<\/p>\n\n\n\n

Avec des op\u00e9rations en Am\u00e9rique du Nord, en France et en Australie, et un pipeline clinique croissant, Kainova ouvre un nouveau chapitre: fa\u00e7onner l’avenir des th\u00e9rapies modulatrices des RCPG, transformer la vie des patients et renforcer sa port\u00e9e mondiale.<\/p>\n\n\n\n

L’\u00e9quipe de direction de Kainova sera \u00e0 San Francisco lors de la conf\u00e9rence J.P. Morgan Healthcare, du 12 au 15 janvier 2026, et se r\u00e9jouit de l’opportunit\u00e9 de partager comment la Soci\u00e9t\u00e9 fait progresser son pipeline clinique de th\u00e9rapies modulatrices des RCPG afin de cr\u00e9er un impact significatif pour les patients.<\/p>\n\n\n\n

###<\/p>\n\n\n\n

Contact<\/strong>
communication@kainovatx.com<\/a><\/p>\n\n\n\n

For English-speaking media:<\/p>\n\n\n\n

Optimum Strategic Communications
Mary Clark, Zoe Bolt, Elena Bates, Nellie Stephens
+44 (0) 203 882 9621
kainova@optimumcomms.com<\/a><\/p>\n\n\n\n

 Lire le communiqu\u00e9 original <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Montr\u00e9al, Canada, Strasbourg, France, Boston, \u00c9tats-Unis: Kainova Th\u00e9rapeutiques (\u00ab Kainova \u00bb ou \u00ab la Soci\u00e9t\u00e9 \u00bb), un catalyseur de traitements r\u00e9volutionnaires pour les patients en immuno-oncologie et en inflammation, a annonc\u00e9 […]<\/p>\n","protected":false},"author":4,"featured_media":1835,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41],"tags":[],"company":[115],"class_list":["post-1851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites-des-compagnies-du-portefeuille"],"yoast_head":"\nDomain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG | adMare<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG | adMare\" \/>\n<meta property=\"og:description\" content=\"Montr\u00e9al, Canada, Strasbourg, France, Boston, \u00c9tats-Unis: Kainova Th\u00e9rapeutiques (\u00ab Kainova \u00bb ou \u00ab la Soci\u00e9t\u00e9 \u00bb), un catalyseur de traitements r\u00e9volutionnaires pour les patients en immuno-oncologie et en inflammation, a annonc\u00e9 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/\" \/>\n<meta property=\"og:site_name\" content=\"adMare\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-12T13:07:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T13:07:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1198\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Earnscliffe Strategies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Earnscliffe Strategies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/\"},\"author\":{\"name\":\"Earnscliffe Strategies\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#\\\/schema\\\/person\\\/bd78e975574bdbf66541602c00a312da\"},\"headline\":\"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG\",\"datePublished\":\"2026-01-12T13:07:31+00:00\",\"dateModified\":\"2026-06-26T13:07:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/\"},\"wordCount\":599,\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zymeworks-en-1768231861-1.png\",\"articleSection\":[\"Actualit\u00e9s des compagnies du portefeuille\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/\",\"name\":\"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG | adMare\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zymeworks-en-1768231861-1.png\",\"datePublished\":\"2026-01-12T13:07:31+00:00\",\"dateModified\":\"2026-06-26T13:07:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zymeworks-en-1768231861-1.png\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/zymeworks-en-1768231861-1.png\",\"width\":1198,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/nouvelles-et-evenements\\\/actualites-et-perspectives\\\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News & Events\",\"item\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/news-events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News & Insights\",\"item\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/news-events\\\/news-insights\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/\",\"name\":\"adMare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#organization\",\"name\":\"adMare\",\"url\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"width\":915,\"height\":337,\"caption\":\"adMare\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/fr\\\/#\\\/schema\\\/person\\\/bd78e975574bdbf66541602c00a312da\",\"name\":\"Earnscliffe Strategies\",\"url\":\"#\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG | adMare","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG | adMare","og_description":"Montr\u00e9al, Canada, Strasbourg, France, Boston, \u00c9tats-Unis: Kainova Th\u00e9rapeutiques (\u00ab Kainova \u00bb ou \u00ab la Soci\u00e9t\u00e9 \u00bb), un catalyseur de traitements r\u00e9volutionnaires pour les patients en immuno-oncologie et en inflammation, a annonc\u00e9 […]","og_url":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/","og_site_name":"adMare","article_published_time":"2026-01-12T13:07:31+00:00","article_modified_time":"2026-06-26T13:07:31+00:00","og_image":[{"width":1198,"height":628,"url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png","type":"image\/png"}],"author":"Earnscliffe Strategies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Earnscliffe Strategies","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#article","isPartOf":{"@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/"},"author":{"name":"Earnscliffe Strategies","@id":"https:\/\/admarebio.com\/fr\/#\/schema\/person\/bd78e975574bdbf66541602c00a312da"},"headline":"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG","datePublished":"2026-01-12T13:07:31+00:00","dateModified":"2026-06-26T13:07:31+00:00","mainEntityOfPage":{"@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/"},"wordCount":599,"publisher":{"@id":"https:\/\/admarebio.com\/fr\/#organization"},"image":{"@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png","articleSection":["Actualit\u00e9s des compagnies du portefeuille"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/","url":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/","name":"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG | adMare","isPartOf":{"@id":"https:\/\/admarebio.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#primaryimage"},"image":{"@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png","datePublished":"2026-01-12T13:07:31+00:00","dateModified":"2026-06-26T13:07:31+00:00","breadcrumb":{"@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#primaryimage","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png","width":1198,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/admarebio.com\/fr\/nouvelles-et-evenements\/actualites-et-perspectives\/domain-therapeutics-devient-kainova-therapeutiques-et-fait-progresser-son-pipeline-clinique-de-therapies-modulatrices-rcpg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admarebio.com\/fr\/"},{"@type":"ListItem","position":2,"name":"News & Events","item":"https:\/\/admarebio.com\/fr\/news-events\/"},{"@type":"ListItem","position":3,"name":"News & Insights","item":"https:\/\/admarebio.com\/fr\/news-events\/news-insights\/"},{"@type":"ListItem","position":4,"name":"Domain Therapeutics devient Kainova Th\u00e9rapeutiques et fait progresser son pipeline clinique de th\u00e9rapies modulatrices RCPG"}]},{"@type":"WebSite","@id":"https:\/\/admarebio.com\/fr\/#website","url":"https:\/\/admarebio.com\/fr\/","name":"adMare","description":"","publisher":{"@id":"https:\/\/admarebio.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admarebio.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/admarebio.com\/fr\/#organization","name":"adMare","url":"https:\/\/admarebio.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/admarebio.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","width":915,"height":337,"caption":"adMare"},"image":{"@id":"https:\/\/admarebio.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/admarebio.com\/fr\/#\/schema\/person\/bd78e975574bdbf66541602c00a312da","name":"Earnscliffe Strategies","url":"#"}]}},"_links":{"self":[{"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/posts\/1851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/comments?post=1851"}],"version-history":[{"count":1,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/posts\/1851\/revisions"}],"predecessor-version":[{"id":1852,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/posts\/1851\/revisions\/1852"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/media\/1835"}],"wp:attachment":[{"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/media?parent=1851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/categories?post=1851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/tags?post=1851"},{"taxonomy":"company","embeddable":true,"href":"https:\/\/admarebio.com\/fr\/wp-json\/wp\/v2\/company?post=1851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}